Impact Assessment on the Consolidation of UK medicines legislation (IA No. 4018)

This impact assessment was produced with regard to measuring the impact of consolidating and simplifying the fragmented legislation regulating medicines.

Read Impact Assessment: Consolidation of UK medicines legislation (PDF, 119K)

Read the Regulatory Policy Committee opinion (PDF, 66K)

In Impact assessments, Transparency | Tagged

Comments are closed.